DeOndra Dixon INCLUDE Project Act of 2025
Latest Action
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Official Summary
DeOndra Dixon INCLUDE Project Act of 2025 This bill provides statutory authority for a program of the National Institutes of Health (NIH) that carries out research and training relating to Down syndrome, including with respect to co-occurring conditions and improving the quality of life of affected individuals. The NIH must implement the program in consultation with relevant stakeholders and avoid duplicating existing NIH Down syndrome research. Biennially, the NIH must submit to Congress a report cataloging the research, including results that may be used in medical care or clinical research.
GovScope Watchdog™
AI Government Intelligence™The DeOndra Dixon INCLUDE Project Act of 2025 establishes a formal program within the National Institutes of Health (NIH) focused on research and training related to Down syndrome. This program aims to address co-occurring conditions and improve the quality of life for individuals with Down syndrome. The NIH is required to collaborate with relevant stakeholders and ensure the program does not duplicate existing research efforts. Additionally, the NIH must provide Congress with a biennial report detailing the research conducted and its potential applications in medical care or clinical research.
This bill creates a statutory NIH program dedicated to advancing Down syndrome research and training, with mandated stakeholder consultation and regular reporting to Congress.
- Establishes statutory authority for an NIH program focused on Down syndrome research and training.
- Requires NIH to consult with relevant stakeholders and avoid duplicating existing research.
- Mandates biennial reporting to Congress on research activities and findings relevant to medical care and clinical research.
['Individuals with Down syndrome and their families', 'National Institutes of Health (NIH)', 'Medical researchers and clinicians specializing in Down syndrome and related conditions', 'Congress, through enhanced oversight and information on Down syndrome research']
['Implementation challenges in coordinating stakeholder consultations and avoiding research duplication', 'Potential costs associated with establishing and maintaining the program and reporting requirements', 'Oversight mechanisms to ensure effective use of resources and adherence to statutory mandates']
The bill was introduced in the House during the 119th Congress and has been received in the Senate, where it was referred to the Committee on Health, Education, Labor, and Pensions. It falls within the health policy area, focusing on federally supported biomedical research and training related to a specific genetic condition.
High concern review — 3 hidden impact flags detected
GovScope reviewed 3 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Improved coordination of Down syndrome research efforts within NIH may lead to more efficient use of federal research funds.', 'Regular reporting to Congress could increase legislative awareness and potentially influence future funding decisions for Down syndrome research.', 'Stakeholder engagement may foster collaboration between researchers, clinicians, and advocacy groups, potentially accelerating translational research and clinical applications.']
The bill mandates biennial reporting to Congress, which provides a mechanism for legislative oversight of the NIH program. The requirement for stakeholder consultation and avoidance of research duplication introduces operational complexities that will require clear guidelines and monitoring. Transparency in how NIH coordinates these efforts and reports outcomes will be important for assessing program effectiveness and resource use.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.